Contrast-induced nephropathy in patients undergoing computed tomography (CONNECT) – a clinical problem in daily practice? A multicenter observational study

References

• Konen E, Konen O, Katz M, Levy Y, Rozenman J, Hertz M. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media? Clin Radiol 2002;57:132–5.
   PubMed Web of Science ®Google Scholar
• Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001;12:3–9
   PubMed Web of Science ®Google Scholar
• Toms AP, Cash CJ, Linton SJ, Dixon AK. Requests for body computed tomography: increasing workload, increasing indications and increasing age. Eur Radiol 2001;11:2633–7.
   Google Scholar
• Kalra MK, Maher MM, Rizzo S, Saini S. Radiation exposure and projected risks with multidetector-row computed tomography scanning: clinical strategies and technologic developments for dose reduction. J Comput Assist Tomogr 2004;28(Suppl 1):S46–S49.
   Google Scholar
• Becker CR, Reiser MF. Use of iso-osmolar nonionic dimeric contrast media in multidetector row computed tomography angiography for patients with renal impairment. Invest Radiol 2005;40:672–5.
   PubMed Web of Science ®Google Scholar
• Kalra MK, Maher MM, D'Souza R, Saini S. Multidetector computed tomography technology: current status and emerging developments. J Comput Assist Tomogr 2004;28(Suppl 1): S2–S6.
   Google Scholar
• Anell A, Willis M. International comparison of health care systems using resource profiles. Bull World Health Organ 2000;78:770–8.
   PubMed Web of Science ®Google Scholar
• CT Overview. IMV Market Research Services [Internet]. Greenbelt, MD, USA [cited August 20, 2009]. Available from: http://www.imvinfo.com/index.aspx?sec=ct&sub=def
   Google Scholar
• Liistro F, Falsini G, Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J 2003;4:668–76.
   PubMedGoogle Scholar
• Adam EJ. Changes in the computed tomography patient population. Eur Radiol Suppl 2006;16(Suppl 4):D38–41.
   Google Scholar
• Segal A, Ellis JH, Baumgartner BR. Manual on contrast media. Sixth. American College of Radiology (ACR) [cited August 20, 2009]. Available at: http://www.acr.org/ SecondaryMainMenuCategories/quality_safety/contrast_ manual.aspx
   Google Scholar
• Thomsen HS, Morcos SK. ESUR guidelines on contrast media. Abdom Imaging 2006;31:131–40.
   PubMedGoogle Scholar
• Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med 2007;33:409–13.
   PubMed Web of Science ®Google Scholar
• Thomsen HS, Morcos SK, Barrett BJ. Contrast-induced nephropathy: the wheel has turned 360 degrees. Acta Radiol 2008;49:646–57.
   PubMed Web of Science ®Google Scholar
• Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615–20.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368–75.
   PubMed Web of Science ®Google Scholar
• Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491–9.
   PubMed Web of Science ®Google Scholar
• Jo SH, Youn TJ, Koo BK, Park JS, Kang HJ, Cho YS, . Renal toxicity evaluation and comparison between Visipaque (iodixanol) and Hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. J Am Coll Cardiol 2006;48:924–30.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Bertrand ME, Brinker JA, Stacul F. A meta-analysis of the renal safety of isosmolar iodixanol compared to low-osmolar contrast media. J Am Coll Cardiol 2006;48:692–9.
   PubMed Web of Science ®Google Scholar
• Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, . Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007;115:3189–96.
   PubMed Web of Science ®Google Scholar
• Solomon R. The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients. Kidney Int 2005;68:2256–63.
   PubMed Web of Science ®Google Scholar
• Solomon R, Dumouchel W. Contrast media and nephropathy: findings from systematic analysis and Food and Drug Administration reports of adverse effects. Invest Radiol 2006;41:651–60.
   PubMed Web of Science ®Google Scholar
• Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, . A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Catheter Cardiovasc Interv 2008;72:958–65.
   Google Scholar
• Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez-Blázquez I, Bastante T, . Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. Rev Esp Cardiol 2009;62:1373–80.
   Google Scholar
• Weisbord SD, Mor MK, Resnick AL, Hartwig KC, Palevsky PM, Fine MJ. Incidence and outcomes of contrast-induced AKI following computed tomography. Clin J Am Soc Nephrol 2008;3:1274–81.
   PubMed Web of Science ®Google Scholar
• Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180–4.
   PubMed Web of Science ®Google Scholar
• Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, . A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812–19.
   Google Scholar
• Nguyen SA, Suranyi P, Ravenel JG, Randall PK, Romano PB, Strom KA, . Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function. Radiology 2008;248:97–105.
   PubMed Web of Science ®Google Scholar
• Thomsen HS, Morcos SK, Erley CM, Grazioloi L, Bonomo L, Ni Z. The ACTIVE Trial: comparison of the effects on renal function of iomeprol-400 and iodixanol-320 in patients with chronic kidney disease undergoing abdominal computed tomography. Invest Radiol 2008;43:170–8.
   PubMed Web of Science ®Google Scholar
• Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31–41.
   PubMed Web of Science ®Google Scholar
• Mehdiratta M. ESUR Guidelines on Contrast Media, Version 6.0. European Society of Urogenital Radiology [cited August 20, 2009]. Available at: http://www.esur.org/ESUR_Guidelines_NEW.6.0.html
   Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39 (Suppl 1):S1–S266.
   Google Scholar
• Renal Association. Chronic kidney disease in adults. UK guidelines for identification, management, and referral. Renal Association, London. 2006 [cited August 20, 2009]. Available at: http://www.renal.org/CKDguide/full/UKCKDfull.pdf
   Google Scholar
• Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393–9.
   PubMed Web of Science ®Google Scholar
• Lameire NH. Contrast-induced nephropathy—prevention and risk reduction. Nephrol Dial Transplant 2000;21 (Suppl 1):i11–23.
   Google Scholar
• Newhouse JH, Kho D, Rao QA, Starren J. Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity. Am J Roentgenol 2008;191:376–82.
   PubMed Web of Science ®Google Scholar
• Morcos SK, Thomsen HS, Webb JA. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). Eur Radiol 1999;9:1602–13.
   PubMed Web of Science ®Google Scholar
• Davidson C, Stacul F, McCullough PA, Tumlin J, Adam A, Lameire N, . Contrast medium use. Am J Cardiol 2006;98(6 Suppl 1):42–58.
   Google Scholar
• Nyman U, Björk J, Aspelin P, Marenzi G. Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention. Acta Radiol 2008;49:658–67.
   PubMed Web of Science ®Google Scholar
• Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, . Volume-to-creatinine clearance ratio. J Am Coll Cardiol 2007;50:584–90.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, . Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98(6 Suppl 1):5–13.
   Google Scholar
• Thomsen HS. European Society of Urogenital Radiology guidelines on contrast media application. Curr Opin Urol 2007;17:70–6.
   Google Scholar
• Stacul F, Adam A, Becker C, Davidson C, Lameire N, McCullough PA, . Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol 2006;98 (6 Suppl 1):59–77.
   Google Scholar
• Thomsen HS, Morcos SK. Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT—a pooled analysis of two randomized trials. Eur Radiol 2009;19:891–7.
   PubMed Web of Science ®Google Scholar
• Sandstede JJ, Roth A, Machann W, Kaupert C, Hahn D. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography. Eur J Radiol 2007;63:120–3.
   Google Scholar
• Mitchell AM, Kline JA. Contrast nephropathy following computed tomography angiography of the chest for pulmonary embolism in the emergency department. J Thromb Haemost 2007;5:50–4.
   PubMed Web of Science ®Google Scholar
• Lufft V, Hoogestraat-Lufft L, Fels LM, Egbeyong-Baiyee D, Tusch G, Galanski M, . Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 2002;40:236–42.
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz C, Martinez-Vea A, Sempere T, Sauri A, Olona M, Peralta C, . Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydratation. Clin Nephrol 2004;61:170–6.
   PubMed Web of Science ®Google Scholar
• Polena S, Yang S, Alam R, Gricius J, Gupta JR, Badalova N, . Nephropathy in critically ill patients without preexisting renal disease. Proc West Pharmacol Soc 2005;48:134–5.
   Google Scholar
• Barrett BJ, Katzberg RW, Thomsen HS, Chen N, Sahani D, Soulez G, . Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol 2006;41:815–21.
   PubMed Web of Science ®Google Scholar
• Kuhn MJ, Chen N, Sahani DV, Reimer D, van Beek EJ, Heiken JP, . The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. Am J Roentgenol 2008;191:151–7.
   PubMed Web of Science ®Google Scholar
• Langner S, Stumpe S, Kirsch M, Petrik M, Hosten N. No increased risk for contrast-induced nephropathy after multiple CT perfusion studies of the brain with a nonionic, dimeric, iso-osmolal contrast medium. Am J Neuroradiol 2008;29:1525–9.
   Google Scholar